AVANDIA

This brand name is authorized in Lithuania, United States

Active ingredients

The drug AVANDIA contains one active pharmaceutical ingredient (API):

1 Rosiglitazone UNII KX2339DP44 - ROSIGLITAZONE MALEATE

Rosiglitazone is a selective agonist at the PPARγ (peroxisomal proliferator activated receptor gamma) nuclear receptor and is a member of the thiazolidinedione class of anti-diabetic agents. It reduces glycaemia by reducing insulin resistance at adipose tissue, skeletal muscle and liver. Read about Rosiglitazone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
AVANDIA Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC
AVANDIA Film-coated tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A10BG02	Rosiglitazone	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BG Thiazolidinediones
Discover more medicines within A10BG02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1004060, 1004061, 1008706, 1008707, 1008708, 1026578, 1026579, 1026580, 1026581, 1026582, 1026583, 1026584, 1026585, 1026586, 1026587, 1026588, 1026589, 1026590
Country: US	FDA, National Drug Code	Identifier(s): 0173-0861, 0173-0863